Aridhia Announces Revolutionary Mini-App Technology to Accelerate Clinical Application Development Following RStudio Collaboration

AridhiaAridhia, the pioneering clinical and translational informatics company, today announced a revolutionary 'mini-app' rapid development solution specifically for clinical applications. The solution integrates the RStudio Shiny web application framework and Shiny Server Pro secure, performant application deployment platform to enhance AnalytiXagility's collaborative workspaces.

All too often the translation of healthcare applications into clinical practice fails due to a breakdown in communication between the data scientists that build analytic models, and the clinical practitioners who consume them.

Chris Roche, CEO at Aridhia, says: "Within one of our collaborative workspaces, any member of a multidisciplinary team, no matter what their role is, will now be able to easily interact with their data - and each other - without the need to understand advanced analytics."

Aridhia's new 'mini-app' rapid prototyping capability embeds RStudio's Shiny reactive data visualisation technology into the company's AnalytiXagility platform, enabling multidisciplinary teams to accelerate the development and deployment of analytically-driven clinical applications.

Data scientists will now be able to rapidly build interactive, visual 'apps', bringing their analysis and data to life, and allowing the rest of their multidisciplinary team to interact with data early in the development lifecycle through an incredible visual experience.

This means for the first time, highly-targeted, prototype healthcare applications can be developed and validated in a matter of hours, rather than weeks.

Roche says: "This morning I asked one of our data scientists to upload a prescribing data set into a workspace. By lunchtime I had several mini-apps in place which I can use to visualise the data in multiple ways at an afternoon meeting. Previously this would have meant several different requests, and a long wait, but now I can interact with the data much more quickly - and without the need for advanced analytic skills."

The healthcare industry is a late and slow adopter of technology, which means that innovations are much slower to disseminate than in other industries. Aridhia believes that a technology-enabled innovation pipeline is critical to facilitating increased collaboration to foster the next generation of patient care innovations, as well as promoting long-term economic growth and healthcare benefits.

Combining the power of R, an advanced analytics language, with modern web technologies, such as Shiny, will allow healthcare and research organisations to exploit the information revolution at a rapid rate.

This is the first time that the Edinburgh-based company Aridhia and RStudio, the Boston company behind free and open source tools for users of the R programming language, have worked together.

The collaboration announcement comes as Aridhia launches the latest version of AnalytiXagility.

"We're absolutely delighted to see how Aridhia has integrated Shiny and Shiny Server Pro into its clinical solution," said Tareef Kawaf, president of RStudio.

"The importance of data science in healthcare is gaining greater awareness. Tools that enable the sharing and understanding of the analytical models to the widest possible audience have become more important than ever before."

"We enjoy seeing what the community can achieve with R," continued Kawaf. "The combination of open technologies which Aridhia has embedded into AnalytiXagility, including R and Shiny, mean that it’s rapidly becoming a crucial component of multidisciplinary, collaborative clinical research and innovation delivery, which can have a significant impact on patient care. We are truly proud to be part of this effort."

This latest version of Aridhia's platform meets two important objectives - delivering a more comprehensive suite of analytic tools to support multidisciplinary research teams, and adding new information governance features that give stakeholders increased control of their data by logging all activity connected to workspaces.

This is Aridhia's first collaboration with RStudio but the latest in a number of pioneering collaborations. Recently, the company announced its partnership with fellow Scottish health tech company Craneware to target the US market, and last year it announced its membership of the Global Alliance for Genomics and Health. Aridhia's data science platform underpins the world-leading Stratified Medicine Scotland Innovation Centre (SMS-IC).

About Aridhia Informatics
Aridhia is a world-leading clinical and translational informatics company developing technology and capability that accelerates the translation of precision medicine and biomedical research into clinical practice. Operating internationally on projects in Australia, England, Scotland and Kuwait, Aridhia works closely with governments, health organisations, research collaborations and academic institutions.

Aridhia was co-founded in 2007 by Dr David Sibbald a software entrepreneur, philanthropist and Vice-President of UK UNICEF, the United Nations children's fund, and Professor Andrew Morris, Chief Scientist for Health in Scotland and Professor of Medicine, Director of the Institute of Population Heath Sciences and Informatics, and Vice-Principal of the University for Data Science at the University of Edinburgh.

Based in Edinburgh and Glasgow, Aridhia has a 60-strong multidisciplinary team of data scientists, information governance specialists, computer scientists, software developers and healthcare experts.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...